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A B S T R A C T
Background
Idiopathic normal pressure hydrocephalus (iNPH) is a type of communicating hydrocephalus also known as non-obstructive hydro-
cephalus. This type of hydrocephalus is caused by impaired cerebrospinal fluid reabsorption without any obstruction in the ventricular
system and is associated with normal cerebrospinal fluid pressure. It is characterised clinically by gait disturbance, cognitive dysfunction,
and urinary incontinence (known as the Hakim-Adams triad). The exact cause of iNPH is unknown. It may be managed conservatively
or treated surgically by inserting a ventriculoperitoneal (VP) or ventriculoatrial (VA) shunt. However, a substantial number of patients
do not respond well to surgical treatment, complication rates are high and there is often a need for further surgery. Endoscopic third
ventriculostomy (ETV) is an alternative surgical intervention. It has been suggested that ETV may lead to better outcomes, including
fewer complications.
Objectives
To determine the effectiveness of ETV for treatment of patients with iNPH compared to conservative therapy, or shunting of CSF
using VP or VA shunts.
To assess the perioperative and postoperative complication rates in patients with iNPH after ETV compared to conservative therapy,
VP or VA shunting.
Search methods
We searched for eligible studies usingALOIS: a comprehensive register of dementia studies, TheCochraneCentral Register ofControlled
Trials (CENTRAL) and several bibliographic databases such as MEDLINE (Ovid SP), EMBASE (Ovid SP), PsycINFO (Ovid SP),
CINAHL (EBSCOhost) and LILACS (BIREME).
We also searched the Database of Abstracts of Reviews of Effects (DARE) to identify potentially relevant reviews. The search strategy
was adapted for other databases, using the most appropriate controlled vocabulary for each. We did not apply any language or time
restrictions. The searches were performed in August 2014.
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Selection criteria
We included randomised controlled trials (RCTs) of ETV treatment of iNPH. Patients had to have at least two symptoms of theHakim-
Adams triad. Exclusion criteria were obstructive causes of hydrocephalus, other significant intracranial pathology and other confirmed
causes of dementia. The eligible comparators were conservative treatment or shunting using VP and VA shunts.
Data collection and analysis
Two review authors independently screened search results, selected eligible studies, assessed risk of bias and extracted data. We contacted
trial authors for additional data.
Main results
Only one study met the inclusion criteria: an RCT comparing effectiveness of ETV and non-programmable VP shunts in 42 patients
with iNPH. The study was conducted in Brazil between 2009 and 2012. The overall study risk of bias was high. The primary outcome
in the study was the proportion of patients with improved symptoms one year after surgery, determined as a change of at least two
points on the Japanese NPH scale. Due to imprecision in the results, it was not possible to determine whether there was any difference
between groups in the proportion of patients who improved 3 or 12 months after surgery (3 months: odds ration (OR) 1.12, 95%
confidence interval (CI) 0.26 to 4.76, n = 42; 12 months: OR 2.5, 95% CI 0.62 to 10.11, n = 38). We were unable to estimate the effect
of treatment on other efficacy outcomes (cognition, balance, function, gait and mobility) because they were inadequately reported. Of
the 26 patients in the VP shunting group, 5 developed subdural hematoma postoperatively, while there were no complications among
the 16 patients in the ETV group (OR 0.12, 95% CI 0.01 to 2.3, n = 42), but the estimate was too imprecise to determine whether
this was likely to reflect a true difference in complication rates. This was also the case for rates of further surgical intervention (OR 1.4,
95% CI 0.31 to 6.24, n = 42). There were no deaths during the trial. We judged the quality of evidence for all outcomes to be very
low because of a high risk of selection, attrition and reporting bias and serious imprecision in the results.
Authors’ conclusions
The only randomised trial of ETV for iNPH compares it to an intervention which is not a standard practice (VP shunting using a
non-programmable valve). The evidence from this study is inconclusive and of very low quality. Clinicians should be aware of the
limitations of the evidence. There is a need for more robust research on this topic to be able to determine the effectiveness of ETV in
patients with iNPH.
P L A I N L A N G U A G E S U M M A R Y
Endoscopic third ventriculostomy for idiopathic normal pressure hydrocephalus
Background
Cerebrospinal fluid (CSF) is the fluid which circulates around the brain and spinal cord and through spaces called ventricles within
the brain. It protects the brain, supplies nutrients and removes waste products. Normally, its production and reabsorption are tightly
controlled. In idiopathic normal pressure hydrocephalus (iNPH), there is an increase in the volume of CSF for unknown reasons.
This causes the ventricles to enlarge and eventually leads to damage to surrounding brain tissue. It usually occurs in older people. Its
characteristic symptoms are deterioration in balance and gait, urinary incontinence and cognitive decline. It is one of the less common
causes of dementia.
It is thought that the symptoms of some patients with iNPH can be improved by an operation to drain away the excess CSF. This has
usually been done by inserting a tube (a shunt) to drain fluid into the chest or abdomen (ventriculoatrial or ventriculoperitoneal shunts).
However, there is uncertainty about the effectiveness of this approach and a significant number of patients develop complications or
need further surgery. Endoscopic third ventriculostomy (ETV) is a newer and less invasive surgical approach which involves making a
small hole in the floor of one of the ventricles.
Review question
We undertook this review to try to determine how safe and effective ETV is for treating iNPH. We did this by looking for any
randomised, controlled trials (RCTs) which compared ETV to no surgery or to insertion of a shunt.
Results
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We searched for trials which had been reported by August 2014. We were able to include only one RCT with 42 participants in
the review. It compared ETV to insertion of a ventriculoperitoneal shunt, but unfortunately a type of shunt which is not often used
in standard practice. We compared the numbers of patients whose symptoms improved with each treatment, but the result was too
imprecise to allow us to draw a conclusion. In the shunting group, 19% of the patients had a surgical complication, while there were
no complications in the ETV group. Due to the small number of participants, we could not be sure whether this was likely to reflect a
true difference in complication rates.
Quality of the evidence
We considered the quality of the evidence to be very low because there was a high risk of bias in the trial results, because the results
were so imprecise, and because several outcomes measured in the trial were not fully reported.
Conclusions
Doctors and patients should be aware of the limitations of the evidence on the effectiveness and safety of this operation for iNPH.
There should be more and larger trials to compare the different treatment options.
B A C K G R O U N D
Description of the condition
Definition
Idiopathic normal pressure hydrocephalus (iNPH) is a clinical syn-
drome of older people (> 60 years) (McGirt 2005). It is coded
G91.2 by ICD-10 (i.e. the 10th revision of the International Sta-
tistical Classification of Diseases and RelatedHealth Problems, the
World Health Organization medical classification. iNPH is char-
acterised by the triad of gait impairment (apraxia), cognitive de-
cline and urinary incontinence (i.e. Hakim-Adams triad). For un-
known reasons it is associated with ventricular enlargement in the
absence of elevated cerebrospinal fluid (CSF) pressure (Marmarou
2005a). The enlargement of ventricles is characteristically triven-
tricular in nature and the hydrocephalus is of the communicating
type.
The term normal pressure (or normotensive) hydrocephalus
(NPH) was devised by Hakim and Adams et al. in 1965
(Marmarou 2005a). There are two types of NPH: primary or idio-
pathic (iNPH) of unknownorigin and secondaryNPHdue to sub-
arachnoid haemorrhage, traumatic brain injury, cerebral infarc-
tion, brain tumours, brain surgery and meningitis (McGirt 2005).
According to data from case-series, substantial improvement after
shunting occurs in 50% to 70% of patients with secondary NPH
and 30% to 50% of patients with iNPH (Black 1985; Vanneste
1992; Vanneste 1994). iNPH is considered one of the few treatable
causes of dementia (Bradley 2000; Marmarou 2007). If treated
on time, iNPH symptoms may be to some extent reverted (Meier
1999).
iNPH has been neurosurgically treated since the 1960s. Consid-
erable experience and knowledge of pathophysiology, biomarkers,
neuroimaging and surgical treatment of iNPH have been accu-
mulated over this time (Hebb 2001). Currently, standard surgi-
cal treatment of iNPH involves shunting of CSF using ventricu-
loperitoneal (VP) or ventriculoatrial (VA) shunts. Traditionally
the diagnosis of NPH could only be confirmed postoperatively by
a favourable outcome to surgical diversion of CSF.
Clinical description
The complete triad is seen in 50% to 75% of patients, with gait
and cognitive disturbances occurring in 80% to 95%, and urinary
incontinence in 50% to 75% of patients (Larsson 1995).
The gait abnormality in iNPH is a frontal gait disorder. Patients
complain about imbalance, tiredness of legs, leg weakness, and, as
the disease progresses, shorter steps, shuffling, scuffing and slow
turning. A hypokinetic gait, associated with a wide base, decreased
step height and disturbance of dynamic equilibrium is considered
’characteristic’ for iNPH (Stoltze 2001). Gait apraxia is often the
first symptom that can be observed and also the first one to resolve
postoperatively (Bradley 2000; Corkill 1999; Damasceno 2009;
Estanol 1981; Nutt 1993). The onset of gait abnormality before
cognitive decline has been reported to predict a better prognosis
after shunting (Fisher 1982; Graff-Radford 1986).
The dementia of iNPH is of subcortical type (Gustafson 1978;
Thomsen 1986) and is characterised by inertia, forgetfulness and
poor executive function (Corkill 1999).
Urinary incontinence usually manifests after gait and cognitive
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disorder. Initially urinary urgency and frequency may be present,
due to detrusor overactivity.
NPH is often misdiagnosed as Parkinson’s disease, Alzheimer’s
disease (and other forms of dementia) and senility owing to its
chronic nature and its presenting symptoms.
As well as clinical history and physical exam, the diagnostic pro-
cedure includes brain imaging.
Useful brain imaging modalities for diagnosis are computerised
tomography (CT), magnetic resonance imaging (MRI) and mag-
netic resonance spectroscopy (MRS).
Imaging studies of the brain are insufficient on their own to diag-
nose iNPH. However, to establish a diagnosis of iNPH in patients
with appropriate symptoms, it is necessary to establish ventricu-
lar enlargement (ventriculomegaly). On CT scans, triventricular
enlargement, not attributable to cerebral atrophy or congenital
disorder, is observed with an Evans’ index ≥ 0.3 (Borgesen 1982;
Bradley 2004; Evans 1942) and corpus callosum angle≤ 40° (Ishii
2008; Sjaastad 1973). Evans’ index is a frontal horn ratio defined
as themaximal frontal horn ventricular width divided by the trans-
verse inner diameter of the skull; it signifies ventricular enlarge-
ment if it is ≥ 0.3 (Gallia 2005). The corpus callosum angle is
another measure used on CT scans to help establish diagnosis of
patients with iNPH. This angle should be < 90° in patients with
iNPH (Gallia 2005).
MRI demonstrates an aqueductal flow void and white matter hy-
perintensities in patients with iNPH (Bradley 1991). In spite of
many diagnostic and measurement tests used, there is no gold
standard for assessing likely success rates for shunt treatment in
iNPH (Klinge 2005). Aqueductal stroke volume above 42 µl is as-
sociated with a favourable outcome after shunting (Bradley 1996).
A lack of white matter lesions on MRI, B-waves longer than 50%
of intracranial pressure monitoring time and resistance to CSF
outflow > 18 mmHg are considered to predict a good response to
operation. A poor response to operation is predicted by severe de-
mentia, dementia as a presenting symptom, MRI abnormalities,
cerebral atrophy and multiple white matter lesions. Misdiagnosis
and delayed recognition may contribute to poor treatment out-
come in iNPH (Relkin 2005). ’Mixing’ of iNPH patients with
those with NPH of known cause may delay appropriate diagnosis
and management of NPH patients (Marmarou 2005a).
Epidemiology
Approximately 6% of all cases of dementia are caused by NPH
(Adams 1981; Meyer 1984; Mullrow 1987). The number of pa-
tients with iNPH is increasing, most likely because of increased
longevity (it is an illness of older people) (Marmarou 2005a;
Marmarou 2005b).
One Norwegian study and two Japanese studies found an inci-
dence of 1.8 to 5.5 per 100,000/year and a prevalence of about 22
per 100,000 (Brean 2008; Hiraoka 2008; Tanaka 2009).
Pathophysiology
Many pathophysiologic abnormalities that may lead to ventricu-
lar enlargement have been reported to occur in iNPH. These in-
clude hyperdynamic aqueduct CSF flow (Bradley 1996), reduced
compliance of the subarachnoid space (Bateman 2000; Bateman
2003), elevated CSF pulse pressure (six to eight times higher than
normal) (Stephensen 2002), impaired (increased resistance to) re-
absorption of CSF in the venous system (Borgesen 1982), abnor-
mal site of CSF reabsorption (transependymal rather than through
Pacchionian granulations) (Edwards 2004; Oi 2006), and cerebral
blood flow reduction (Owler 2001). The precise pathophysiologic
pathway remains unclear (McGirt 2005).
The gait symptoms have been ascribed to the increased intracra-
nial pressure, with presumed secondary stretching and compres-
sion of the fibres of the corticospinal tract in the corona radi-
ata that supply the legs and that pass in the close vicinity to the
lateral ventricles. As the ventricles continue to enlarge and the
cortex is pushed against the inner table of the calvarium, radial
shearing forces lead to dementia (Hakim 1976). There is an in-
creased incidence of subcortical, deep white matter hyperintensi-
ties on T2-weightedMRI images (Bradley 1991; Jack 1987; Kraus
1996, Kraus 1997). These changes probably represent small vessel
ischaemia, supported by the finding of decreased cerebral blood
flow (Bradley 1991; Kristensen 1996; Mamo 1987; Tanaka 1997;
Waldemar 1993). At an early stage the periventricular sacral fibres
of the corticospinal tract are stretched causing a loss of voluntary
(supraspinal) control of bladder contractions (Gleason 1993); in
later stages of the disease, the dementia may contribute to incon-
tinence (Corkill 1999).
Description of the intervention
Endoscopic third ventriculostomy (ETV) is a surgical procedure
in which an opening is created in the floor of the third ventricle.
The standard procedure involves insertion of a flexible or rigid
endoscope through a right precoronal burr hole and a small cor-
ticotomy. Perforation of the floor of the third ventricle (using a
coagulation probe) is performed to the mamillary bodies and the
tuber cinereum enabling pulsations of the floor of the third ven-
tricle.
ETV is a minimally invasive surgery that has been used routinely
since 1993, mainly for the treatment of obstructive hydrocephalus
and intracranial CSF cysts (Gangemi 2004). In 1999,Mitchell and
Mathew were first to report the use of ETV for treating iNPH in
a series of four patients (Gangemi 2004; Hailong 2008; Mitchell
1999). The largest reported series of ETV in iNPH with a long
follow-up period (2 to12 years; median, 6.5 years) by Gangemi
2008 showed that both ETV and shunting have a similar mecha-
nism. However, ETV seems to be more physiologic than shunting,
which can often cause significant overdrainage and lead to shunt
dependence.
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Postoperative complications include intracerebral haematoma of
the right frontal region, subdural haematoma, CSF leak and
wound infections (Gangemi 2008).
How the intervention might work
The exact cause of iNPH is yet to be determined (McGirt 2005).
There are several theories regarding the origin of this condition
such as an extraventricular intracisternal CSF pathway obstruc-
tion, increased transmantle pressure gradient, a transmantle pul-
satile stress or a combination of these. If iNPH is a consequence
of CSF pathway obstruction, ETV could then potentially act as
an internal shunt by reabsorbing CSF in the dural venous system
and bypassing the aqueduct and the CSF pathways of the poste-
rior fossa (Kehler 2003). However, in a series of iNPH patients
examined neuroendoscopically, an absence of CSF pathway ob-
struction was observed in most cases and stated as the reason for
failure of subsequent ETV treatment (Longatti 2004). However,
if we accept the theory that the increased transmantle pressure
gradient or a transmantle pulsatile stress, or both (from inside to-
ward the subarachnoid space) lead to iNPH, ETV could work as
an opening in the bottom of the third ventricle enabling greater
systolic CSF outflow into the subarachnoid space, reducing the
intraventricular pulse pressure and thus the size of the ventricles
(Gangemi 2008).
Why is it important to do this review
Currently, common methods of treatment for patients with iNPH
are conservative therapy (i.e. no surgical intervention, manage-
ment of symptoms) or shunting of CSF using VP or VA shunts
(Bergsneider 2005; Krauss 2004). However, substantial numbers
of patients do not respond to shunting (Bergsneider 2005; Hebb
2001). Considering high complication rates and a frequent need
for further surgery, it is evident that shunting has limitations
(Meier 2000). Furthermore, a Cochrane review published in 2009
found no evidence of effectiveness of shunting forNPH (Esmonde
2009).
Although a success rate of 73.4% for treating iNPHwith ETV has
been reported (Gangemi 2008), there is no clear evidence about
comparative effectiveness for ETV, andVP and VA shunting. That
is, there is so far no clear evidence about whether ETV has any
advantages over shunting procedures and whether it should be
preferred in the treatment of iNPH (Meier 2003). This systematic
review aims to summarise the evidence to date and will be updated
to include new evidence as it accumulates.
O B J E C T I V E S
• To determine the effectiveness of ETV for treatment of
patients with iNPH compared to either conservative therapy or
shunting of CSF using VP or VA shunts.
• To assess the perioperative and postoperative complication
rates in patients with iNPH after ETV compared to conservative
therapy, VP or VA shunting.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) of ETV treat-
ment of iNPH.
Types of participants
We considered eligible studies on patients with iNPH. Patients
had to have two symptoms of an Adams-Hakim triad: gait apraxia,
dementia, urinary incontinence (using either Kiefer or Japanese
Committee for Scientific Research on Intractable Hydrocephalus
grading systems) (Ishikawa 2008; Kiefer 2003). Other diagnostic
criteria such as dilatation of all four ventricles, resistance to CSF
outflow > 18 mmHg, B waves during preoperative intracranial
pressure recording, good responses to spinal tap/lumbar drainage
and aqueductal stroke volume of 42 µl were not used as inclusion
criteria since they are not routinely performed in patients with
iNPH. However, we report them in our review as they could be a
source of heterogeneity.
Exclusion criteria were obstructive causes for hydrocephalus, other
significant intracranial pathology and other confirmed causes of
dementia.
Types of interventions
ETV for treatment of patients with iNPH. The eligible compara-
tors were conservative treatment or shunting using VP and VA
shunts.
Types of outcome measures
Primary outcomes
• Postoperative change in clinical signs and symptoms of
iNPH measured using validated assessment tools. These were
divided into:
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◦ short-term outcomes (up to and including six
months);
◦ long-term outcomes (measured more than six months
postoperatively);
• Postoperative complications, perioperative mortality and
morbidity rates.
Secondary outcomes
• Long-term complications (infection, CSF fistula,
overdrainage).
• A need for further surgical treatment.
• Ventricle width in the postoperative period.
• Changes in measurements of diagnostic tests (e.g. MRI,
CT).
• Total mortality over a trial.
Search methods for identification of studies
Electronic searches
The search strategy was developed and performed by the The
Cochrane Dementia and Cognitive Improvement Group trial
search coordinator. The following electronic databases were
searched for eligible studies:
1. ALOIS: a comprehensive register of dementia studies.
ALOIS is the specialised register of the Cochrane Dementia and
Cognitive Improvement Group that contains records of
controlled trials identified from monthly searches of a number of
major healthcare databases, trials registers and grey literature
sources. For a full list of sources searched for ALOIS, see About
ALOIS at the following link - http://www.medicine.ox.ac.uk/
alois/content/about-alois ;
2. The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2014, Issue 7);
3. Bibliographic databases: MEDLINE (Ovid SP), EMBASE
(Ovid SP), PsycINFO (Ovid SP), CINAHL (EBSCOhost),
LILACS (BIREME).
The Database of Abstracts of Reviews of Effects (DARE) (The
Cochrane Library 2014, Issue 7) was also searched to identify po-
tentially relevant reviews.
We used the strategy outlined in Appendix 1 to searchMEDLINE
which was adapted for other databases, using themost appropriate
controlled vocabulary for each. We did not apply any language
restrictions.The search was conducted in August 2014 without
any time limits.
Searching other resources
For the included study, we conducted author and citation searches
in Science Citation Index database.
Data collection and analysis
Selection of studies
Two review authors (MT and KIT) independently examined titles
and abstracts of citations obtained from the searches and excluded
obviously ineligible articles. We then obtained the full-text report
for only one study which met the inclusion criteria. We indepen-
dently assessed the retrieved paper for inclusion in the review using
pre-defined inclusion and exclusion criteria.
Data extraction and management
Two review authors (MT and KIT) independently retrieved infor-
mation on the study design, participants, and intervention out-
comes and results from the study using a standardised data ex-
traction form. We resolved any potential disagreements about the
extracted data by discussion. We contacted authors for missing
information on study outcomes.
For each outcome measure, we searched for available data on ev-
ery randomised patient. We planned to perform an intention-to-
treat (ITT) analysis of available data. However, the information
available in the only eligible study found, did not allow this ap-
proach. This is because five participants initially randomised to
the ETV group were reassigned to, and analysed as, a part of the
VP shunting group.
Assessment of risk of bias in included studies
Two review authors (MT andKIT) independently assessed the risk
of bias for each included study, using the ’Risk of bias’ tool from
Chapter 8.5 of the Cochrane Handbook of Systematic Reviews of
Intervention (Higgins 2011), with any differences resolved by dis-
cussion and consensus. The tool includes the following domains:
sequence generation, allocation concealment, blinding of partici-
pants, personnel and outcome assessors, incomplete outcome data,
selective outcome reporting and other sources of bias.
We analysed the included study and assigned a judgment relating
to the risk of bias for each item. We used a template to guide the
assessment of risk of bias judging each item as ’yes’ (indicating a
low risk of bias), ’no’ (indicating a high risk of bias) or ’unclear’
(indicating an uncertain risk of bias). We summarised the risk of
bias for each outcome.
We also assessed a range of other possible sources of bias and
indicators of study quality, including: baseline comparability of
groups, validation of outcome assessment tools and reliability of
outcome measures.
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We presented the results of the ’Risk of bias’ assessment in a table
and incorporated the results of the assessment of risk of bias into
the review through systematic narrative description and commen-
tary about each of the quality items, for the included study. We
were unable to make to make an overall assessment of the risk of
bias in the included studies and a judgment about the possible
effects of bias on the effect sizes of the included studies as initially
intended as we only found one eligible study.
Measures of treatment effect
For binary outcomes, such as clinical improvement or no clinical
improvement, we presented the outcomes using odds ratio (OR)
and 95% confidence intervals (CI). For continuous outcomes, we
planned to report the mean difference (MD) and 95% CI.
Unit of analysis issues
We followed Cochrane Handbook of Systematic Reviews of Interven-
tion recommendations (Deeks 2011) to resolve potential unit of
analysis issues. Repeated measurements (i.e. outcomes assessed at
different time pointswithin the same trial) were analysed separately
as short-term (assessed up to six months post-intervention) and
long-term (more than six months post-intervention) outcomes.
Assessment of reporting biases
Weplanned to include studies published in any language to address
the language bias. In order to minimise the risk of publication
bias, we performed a comprehensive search in multiple databases
(including unpublished results)
Data synthesis
Although we planned to assess all studies qualitatively and subse-
quently, if appropriate, perform a meta-analysis (using a random-
effects model), this was unfeasible as only one study was included.
Subgroup analysis and investigation of heterogeneity
In terms of the subgroup analyses, our aim was, if collected data
allowed, to perform subgroup analyses according to age, co-mor-
bidities, gender and duration of symptoms. We planned to exam-
ine protocols for the selection of iNPH patients for ETV used in
the analysed studies and form subgroups of patients, depending
on additional diagnostic tests used to confirm the diagnosis, and
then perform subgroup analysis. Given that we only included one
eligible study, the planned subgroup analyses were unfeasible.
Sensitivity analysis
We planned to undertake sensitivity analyses based on the ’Risk
of bias’ assessment of the included studies and if possible remove
studies with the highest risk of bias from the analysis. However,
this was unfeasible as only one study was included.
R E S U L T S
Description of studies
Results of the search
The search strategy yielded 3004 potentially relevant references.
The number of records that remained after duplicates were re-
moved was 2669. Screening of titles and abstracts resulted in
only one paper retrieved in full text which was in the end in-
cluded (Pinto 2013). Author Science Citation Index database
search yielded 78 citations which were deemed ineligible. Cita-
tion Science Citation Index database search resulted in five stud-
ies which did not fit our inclusion criteria. We did not find any
relevant conference proceedings or on-going trials. Figure 1 shows
the search process and study selection with the adapted PRISMA
flow-diagram.
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Figure 1. Study flow diagram.
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Included studies
We found only one eligible study (Pinto 2013). Key characteristics
of the included study are summarised in the ’Characteristics of
included studies’ table. This study was an RCT, in which the unit
of randomisation was the individual patient. The study was con-
ducted from January 2009 to January 2012 on patients with iNPH
at the Institute of Psychiatry, Hospital das Clinicas, Faculdade de
Medicina da Universidade de São Paulo, Brazil. The objective of
the study was to compare functional neurological outcome in pa-
tients with iNPH 12 months after treatment with either ETV or
VP shunting. The sample size was 42. The authors’ hypothesis
was that iNPH treatment with VP shunting is the superior option
compared to ETV.
The study participants included 24 men and 18 women, aged
from 60 to 75 years. All participants had a diagnosis of probable
iNPH. The diagnostic criteria for probable iNPH consisted pri-
marily of clinical criteria, as well as radiological and manometric
criteria. Further inclusion criteria were the duration of symptoms
for 24 months, preserved ambulation with 2 supports, absence
of other dementia syndromes, absence of malignant disease, com-
pensated clinical co-morbidities (hypertension, diabetes mellitus,
hormonal disorders), positive result of the tap test (TT) (Wikkelsø
2013), and free and informed consent signed by patients and fam-
ily members. The TT is a common prognostic test used to select
patients for shunt surgery (Marmarou 2005b). In this study, the
TT was performed preoperatively to determine the CSF pressure
and therapeutic prognosis by withdrawing 40 ml of CSF.
ETV was performed via a right precoronal burr hole (Kocher
point) with a rigid ventricular neuroendoscope containing a 30
lens (Minop, Aesculap). The the floor of the third ventricle was
perforated in themidline halfway between themammillary bodies
and the infundibular recess. An inflating balloon of a 4F Fogarty
catheter was used to enlarge the fenestration. The ventriculostomy
size was approximately 4 mm to 6 mm.
VP shunting was performed via a right precoronal burr
hole (Kocher point). The chosen valve pressure (PS Medical,
Medtronic) was based on the final manometry value at the TT. Af-
ter the removal of 40 ml of CSF, a low-pressure valve was inserted
with the final pressure of 4 cm H2O; a final pressure between 4
cm and 10 cm H2O resulted in the administration of a medium-
pressure valve; and a final pressure of 10 cm H2O resulted in the
administration of a high-pressure valve.
Outcomes were measured with the following validated scales be-
fore and after surgery: theNPH Japanese Scale (NPHScale) (Mori
2001), the Berg Balance Scale (BERG) (Berg 1992;Miyamoto
2004), the Dynamic Gait Index (DGI) (Marchetti 2006), the
Functional Independence Measure (FIM) (Linacre 1994), the
Mini-Mental Status Examination (MMSE) (Folstein 1975), and
the Timed Up and Go (TUG) (Schoene 2013). All patients were
followed for 12 months, with prescheduled consultations at 3,
6, and 12 months after surgery. The patients were evaluated ac-
cording to the scales at 3 and 12 months. The primary outcome
measure in this study was the proportion of patients showing im-
provement of symptoms after one year using the NPH scale. The
authors state that “after 1 year, the late postoperative result was
classified as positive if the patient had at least a 2 points higher
score on the NPH Scale”, although higher scores on this scale ac-
tually indicate poorer outcomes. No definition is given for a pos-
itive outcome after three months. The outcomes measured using
other scales were considered secondary outcomes. Surgical com-
plications were presented for both groups of patients.
Excluded studies
The only study for which we retrieved the full text was included
in the review. We therefore do not present any excluded studies,
as no study was excluded at the full-text screening stage.
Risk of bias in included studies
Overall, we judged the included RCT to have a high risk of bias.
The ’Characteristics of included studies’ table, Figure 2 and Figure
3 present the relevant information.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
We judged that themethods of sequence generation and allocation
concealment in the includedRCTwere adequate: a random choice
of opaque white sealed envelopes containing the name of one of
the two procedures by an independent physician from the surgical
ward. However, five participants who had been randomly assigned
to ETVwere actually treated with VP shunting because at the time
of surgery the surgeon judged them to be unsuitable for ETV due
to anatomical variations. These participants were analysed in the
VP shunting group. Hence, we judged there to be an overall high
risk of selection bias. Blinding of the participants and personnel
in the study was not possible. We believe this did not influence
outcome and therefore the risk of performance bias was judged
to be low. The risk of detection bias was judged to be unclear
since we could not find any information in the study about the
blinding of the outcome assessors. We judged the study to have
a high risk of attrition bias as 4 patients in the ETV group who
were judged unimproved after 3 months were treated with VP
shunting and excluded from the primary outcome analysis at 12
months. We judged the study to have a high risk of reporting bias
since no continuous outcomes were reported in sufficient detail
to allow calculation of mean differences (only average, maximum
and minimum presented in a table) and the study authors have
not responded to a request to provide the standard deviations.
Effects of interventions
Short-term (<6 months after surgery) and long-term (> 6
months after surgery) postoperative change in clinical signs
and symptoms of iNPH
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The study authors report that 12 of the 16 patients in the ETV
group and 20 of the 26 patients in the VP shunting group showed
clinical improvement after 3 months, but it is not clear how im-
provement at this time point was defined. We did use these figures
to calculate an odds ratio, but due to the small sample size, the
effect estimate was very imprecise and it was not possible to deter-
mine whether there was any difference between groups (OR 1.12,
95% CI 0.26 to 4.76, n = 42, 1 study). We judged this evidence to
be of very low quality due to very serious imprecision and serious
risk of bias.
At 12 months, 4 patients from the ETV group who had not im-
proved at 3 months had been treated with VP shunting and were
excluded from the analysis. The study authors reported that 8 of
the 12 remaining patients in the ETV group and 20 of the 26
patients in the VP shunting group showed clinical improvement.
This had been defined as an increase of at least 2 points on the
NPH scale, but we assumed that the authors meant a decrease
of at least 2 points (lower scores on this scale indicating better
outcome). Again, it was not possible to determine any difference
between the groups (OR 2.5, 95% CI 0.62 to 10.11, n = 38, 1
study). We judged this to be very low quality evidence due to very
serious imprecision and very serious risk of bias.
Other efficacy outcomes (cognition, balance, function, gait and
mobility) were measured at 3 and 12 months, but the results were
reported only as “average” and range. No standard deviations were
reported and the authors have not responded to our request for
additional data. Hence, we were not able to calculate mean dif-
ferences between the groups with confidence intervals for any of
these outcomes.
Postoperative complications and long-term complications (in-
fection, CSF fistula, overdrainage)
There were no postoperative complications in the ETV group. In
the VP group, 5 of the 26 patients (19%) who underwent implan-
tation of a low-pressure valve had overdrainage with a significant
reduction in ventricular size and a chronic subdural haematoma.
Due to imprecision of the effect estimate, it was not possible to
determine whether the interventions differed in the rate of post-
operative complications (OR 0.12, 95% CI 0.01 to 2.3, n= 42, 1
study). We judged this to be very low quality evidence due to very
serious imprecision and very serious risk of bias.
A need for further surgical treatment
Four of the 16 patients (25%) receiving ETV who showed no
improvement at three months post surgery were submitted to VP
shunting. In the VP shunting group, 5 of the 26 patients (19%)
experienced overdrainage and underwent another operation with
implantation of a medium-pressure valve. Again, the effect es-
timate was very imprecise and it was not possible to determine
whether there was a difference between the interventions in the
need for further surgical treatment (OR 1.4, 95%CI 0.31 to 6.24,
n = 42 , 1 study). We judged this to be very low quality evidence
due to very serious imprecision and very serious risk of bias.
Ventricle width in the postoperative period and changes in
measurements of diagnostic tests (e.g. MRI, CT)
Ventricular size on CT scan was measured preoperatively and six
months postoperatively, but data were given only as means and
ranges.
Total mortality
No patients died during the study.
D I S C U S S I O N
Summary of main results
The only included study provides no evidence that either ETV
or VP shunting is associated with better outcomes for patients
with iNPH (Pinto 2013). Many outcomes were inadequately re-
ported and, where we were able to calculate effect estimates with
confidence intervals, these were extremely imprecise. The results
were compatible with no difference or with superiority of either
intervention. While none of the 16 ETV patients had complica-
tions, 5 of the 26 patients submitted to VP shunting developed
overdrainage and chronic subdural haematoma, but the sample
size was too small to draw any definitive conclusion from this.
Overall completeness and applicability of
evidence
In this review, we performed a thorough search of the available
literature on the effectiveness of ETV compared to all other cur-
rently employed types of treatment. Nevertheless, we only found
one eligible trial that assessed the effectiveness of ETV compared
to VP shunting. This trial had serious limitations. The included
evidence does not provide robust and generalisable answers to the
review questions.
The included study was performed in Brazil and included elderly
patients with the diagnosis of probable iNPH, with 1 to 2 symp-
toms, duration of symptoms of 24 months, preserved ambulation
with 2 supports, absence of other dementia syndromes and ma-
lignant disease, compensated clinical co-morbidities, positive TT
result, and free and informed consent signed by patients and fam-
ily members. The sample size was small. Five patients were re-allo-
cated post-randomisation from ETV to VP shunting group. The
comparator used was non-programmable VP shunts which are no
longer a standard treatment for people with iNPH. The presented
data on continuous outcomes lack relevant summary measures to
allow statistical analysis and comparison.
Quality of the evidence
The study had 42 participants andwas judged to have a high risk of
bias. Using GRADE criteria, we judged the evidence to be of very
low quality (Schünemann 2011). The evidence presented in this
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review has serious limitations relating both to the risk of bias (high
risk of selection, attrition and reporting bias) and to imprecision
in the effect estimates (inclusion of only one small study).
Potential biases in the review process
We rigorously followed the Cochrane review methodology and
performed a comprehensive search without any limitations. In our
opinion, it is unlikely that we missed any other relevant study,
either published, from grey literature or on-going.
Agreements and disagreements with other
studies or reviews
An Italian multicenter retrospective study published in 2008 re-
ported outcomes of the ETV treatment. This study reported a suc-
cess rate of 69.1% for ETV treatment in 110 patients with iNPH
after a follow-up period of at least 2 years. The study had several
limitations such as a lack of a clear distinction between the cases
of iNPH and possible cases of secondary NPH, and the use of the
monitoring of intracranial pressure as a predictive functional test
rather than the TT, the lumbar infusion test, and external lumbar
drainage monitoring for 72 hours (Gangemi 2008). Another case
series presented 14 cases with apparently idiopathic NPH treated
by ETV and reported a low rate of success (21%) (Longatti 2004).
A study on perioperative safety of ETV for iNPH compared with
VP shunting that used a nationwide database reported that ETV
was associated with higher perioperative mortality and complica-
tion rates compared with VP shunting. In this review, the only eli-
gible study we found had no complications (either short- or long-
term) associated with ETV (Chan 2013).
The findings from these three studies are diverse and different
to the outcomes reported in the RCT included in this review.
There is a clear need for larger, methodologically robust RCTs to
provide reliable evidence on the effectiveness of ETV in patients
with iNPH.
Authors’ conclusions
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence we found was inconclusive for all outcomes and of
very low quality.When choosing a surgical intervention for iNPH,
clinicians should be aware of the limitations of the evidence base.
Implications for research
There is a lack of evidence on the effectiveness of ETV in pa-
tients with iNPH. The only eligible study we found had a high
risk of bias, a small sample size and used VP shunts with non-
programmable valves. There is a need for larger randomised con-
trolled trials comparing ETV with the currently recommended
treatment - VP shunting with a programmable valve. The authors
of the included study reported that oscillations of the third ventri-
cle floor observed intra-operatively were associated with improve-
ment in the ETV group. Future trials should consider following
up this observation by undertaking relevant subgroup analyses.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Pinto 2013
Methods Parallel, open-label randomised controlled trial
Participants Eligble participants were patients with diagnosis of probable iNPH, aged 55 to 75 years,
duration of symptoms 24 months, preserved ambulation even with 2 supports, absence
of other dementia syndromes, absence of malignant disease, compensated clinical co-
morbidities (hypertension, diabetes mellitus, hormonal disorders), positive TT result,
and free and informed consent signed by patients and family members
A total of 42 participants were included in the study and randomised into two groups of
21 patients. However, 5 patiens from the ETV group were subsequently reallocated to
VP shunting group due to anatomical characteristics which made ETV inappropriate.
ETV group consisted of 16 patients with 9 men and 7 women. The mean age was 70
years, ranging from 60 to 75 years. VP shunting group consisted of the 21 patients
randomly assigned to the VP shunting group and the 5 patients reallocated from ETV
group. 15 were men and 11 were women. The mean age was 71 years, ranging from 62
to 73 years
Interventions Intervention was ETV which was performed with a rigid endoscope with a 30 lens
(Minop, Aesculap). The comparison consisted of VP shunting
which was performed with a fixed-pressure valve (PS Medical, Medtronic)
Outcomes The primary outcome was improvement of neurological function one year after surgery
measured as 2 points improvement on theNPH Japanese Scale. The secondary outcomes
included improvement determined thorough the use of other scales (e.g. TheMini-men-
tal Status Examination, the Berg Balance Scale, the Dynamic Gait Index, the Functional
Independence Measure, the Timed Up and Go) and surgical complications
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The allocation sequence was adequately
generated. The authors state: “An indepen-
dent physician from the surgical ward of the
hospital randomly chose between 2 equally
sized and opaque white sealed envelopes
that were placed side to side over a table.
Each envelope contained a white sheet of
paper with the name of a procedure on it
(either VPS or ETV), thus choosing the in-
tervention to be performed.”
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Pinto 2013 (Continued)
Allocation concealment (selection bias) High risk The allocation of participants in the study
was adequately concealed. As above, au-
thors state: “the surgical ward of the hos-
pital randomly chose between 2 equally
sized and opaque white sealed envelopes
that were placed side to side over a table.
Each envelope contained a white sheet of
paper with the name of a procedure on it
(either VPS or ETV), thus choosing the
intervention to be performed.” However,
5 participants who had been randomly as-
signed to ETV were actually treated with
VTP due to anatomical variations found at
surgery and were analysed in theVT shunt-
ing group. Hence, we judged there to be an
overall high risk of selection bias
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The blinding of participants and personnel
was unfeasible. We believe this did not in-
fluence outcome and therefore the risk of
performance bias was judged to be low
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk There is no information on blinding of out-
come assessors.
Incomplete outcome data (attrition bias)
All outcomes
High risk Four patients in the ETV group who were
judged unimproved after three months
were treated with VP shunting and ex-
cluded from the primary outcome analysis
at 12 months
Selective reporting (reporting bias) High risk No continuous outcomes were reported
in sufficient detail to allow calculation of
mean differences (only average, max and
min presented in a table) and the study au-
thors have not responded to a request to
provide the standard deviations
Other bias Low risk
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. MEDLINE (Ovid SP) search strategy
1. “idiopathic normal pressure hydrocephalus”.ti,ab.
2. Hydrocephalus, Normal Pressure/
3. (wet ADJ wobbly ADJ wacky“.ti,ab.
4. ”weird ADJ walking ADJ water“.ti,ab.
5. ”normotensive hydrocephalus“.ti,ab.






12. Cerebrospinal Fluid Shunts/





18. 9 and 17
Appendix 2. Glossary
Arachnoid mater: one of the three meninges, the protective membranes that protect the brain and spinal cord, located between the
two other meninges - the more superficial and much thicker dura mater and the deeper pia mater, from which it is separated by the
subarachnoid space.
Cerebrospinal fluid (CSF): is the fluid which circulates around the brain and spinal cord and through spaces called ventricles within
the brain. It protects the brain and the spinal cord, supplies nutrients and removes waste products.
Communicating hydrocephalus: type of hydrocephalus in which the openings between the ventricular spaces, and between the fourth
ventricle and the subarachnoid space, are working.
Corpus Callosum: a broad band of nerve fibres linking the two brain hemispheres.
Coronal suture: seam between the frontal and the parietal bones.
Corticotomy: removal of a part of bone cortex while leaving the intramedullary blood supply intact
CSF shunt: a tube surgically sited in the body that channels cerebrospinal fluid away from the brain or spinal cord into another part
of the body, where it can be absorbed and transported to the bloodstream.
Dura mater: the top layer of the meninges underneath the bone tissue.
Dural venous sinuses: venous channels found between layers of dura mater in the brain. They receive blood from internal and external
veins of the brain, receive cerebrospinal fluid and finally empty into the internal jugular vein.
Endoscopic third ventriculostomy (ETV): a surgical operation that forms an opening through the membranous floor of the third
ventricle, allowing cerebrospinal fluid to leave the third ventricle and flow directly into the subarachnoid space at the brain base.
Hakim-Adams triad: classic symptom triad associatedwith iNPH- deterioration in balance and gait, urinary incontinence and cognitive
decline
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Hydrocephalus: an abnormal condition that occurs when there is an imbalance between the rate of cerebrospinal fluid production and
the rate of absorption, leading to gradual accumulation of CSF.
Idiopathic normal pressure hydrocephalus (iNPH): type of adult-onset hydrocephalus without known cause with symptoms such as
difficulty walking, mild dementia, and impaired bladder control. This form of hydrocephalus occurs most often in people over age 60.
Intracranial pressure (ICP): pressure caused by a build-up of cerebrospinal fluid, resulting in hydrocephalus.
Lateral ventricles: part of the ventricular system of the brain located in each cerebral hemisphere. The lateral ventricles are the largest
of the ventricles.
Meninges: the three membranes (the dura mater, arachnoid, and pia mater) that coat the skull and vertebral canal and enfold the brain
and spinal cord.
Pacchionian granulation: the arachnoid membrane projections into the dural sinuses that allow CSF entrance from the subarachnoid
space to the venous system.
Pia mater: the delicate innermost membrane surrounding the brain and spinal cord.
Subarachnoid space: the anatomic space between the arachnoid mater and the pia mater, the two membranes that surround the brain
and the spinal cord.
Transmantle pressure: the difference between the intraventricular pressure and the pressure inside the subarachnoid spaces of the
cerebral convexity.
Third ventricle: a midline brain cavity that is located between the right and left thalamus. Cerebrospinal fluid enters the third ventricle
from each lateral ventricle via the foramen of Monro; it exits the third ventricle via the aqueduct of Sylvius.
Ventricle: a cavity within the brain that contains cerebrospinal fluid.
Ventriculoatrial (VA) shunt: a shunt that is placed into a brain ventricle to drain cerebrospinal fluid (CSF) from the ventricular system
into the heart.
Ventriculoperitoneal (VP) shunt: a shunt that is placed into a brain ventricle to drain cerebrospinal fluid (CSF) from the ventricular
system into the abdomen.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
There are a number of differences between the protocol and the present review. These differences are mainly because only one study
met the inclusion criteria and they are mostly in the data analysis section.
Data analysis
If we had found more than one eligible study, we would have presented a summary of the treatment effect. Moreover, we would have
analysed the outcomes using RevMan 2014, and intention-to treat principle of analysis (Unnebrink 2001). If sufficient number of
eligible studies had been available, we would have aimed to summarise data statistically. We planned to present dichotomous data
as odds ratios with 95% confidence intervals (95% CI). For continuous outcomes we wanted to calculate the mean difference with
95% CI. We wanted to calculate overall results based on a random effects model. If heterogeneity had been detected and it had been
appropriate to combine the trials, we would have used a random-effects model.
Assessment of heterogeneity
We felt it was important to consider heterogeneity in this review, given the fledgling nature of this field.Hadwe found substantial clinical,
methodological or statistical heterogeneity, we would not have combined the results in a meta-analysis and would have performed a
narrative overview of the findings. We planned to identify heterogeneity by visual inspection of forest plots, by using a standard Chi2
test and a significance level of alpha = 0.1, in view of the low power of such tests. We would also have examined heterogeneity with the
I2 statistic, where I2 values of 50% or more indicate a substantial level of heterogeneity (Higgins 2003). We would have attempted to
determine potential reasons for heterogeneity by examining individual study characteristics of the main body of evidence.
Reporting bias
To test the likelihood of reporting bias in the included studies, we planned to use funnel plots. We wanted initially to test for funnel
plot asymmetry by visual inspection. If we had included more than 10 studies, funnel plot asymmetry would have been tested using
the test proposed by Egger 1997. If funnel plot asymmetry had been determined, we would have discussed its possible causes (Sterne
2011).
Data synthesis
Wewould have performedmeta-analysis if a group of included studies was sufficiently homogenous. We would have separately analysed
the results of the different study types and for the different outcomes. If statistical pooling of results had been inappropriate, we would
have undertaken a narrative overview of the results. We would have systematically described each included study according to setting,
participants, control, and outcomes. We would have grouped the included studies according to duration of the study and performed
separate meta-analyses. We would have presented each included study in a “Characteristics of included studies” table and we would
have provided a risk of bias assessment and quality assessment of included studies.
Subgroup analysis and investigation of heterogeneity
If there had been sufficient trial data, we would have performed subgroup analyses according to age, co-morbidities, gender and duration
of symptoms. We would have examined protocols for the selection of iNPH patients for ETV used in the analysed studies and formed
subgroups of patients, depending on additional diagnostic tests used to confirm the diagnosis of iNPH. These diagnostic tests (such
as resistance to CSF outflow, spinal tap/lumbar drainage, etc.) have different sensitivities, as well as positive and negative predictive
values and represent a potential source of heterogeneity. If we had found a sufficient number of studies employing different diagnostic
modalities to confirm the diagnosis of iNPH, we would have performed subgroup analysis based on different diagnostic tests.
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Sensitivity analyses
We planned to undertake sensitivity analyses based on the ’Risk of bias’ assessment of the included studies.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cerebrospinal Fluid Shunts [methods]; Hydrocephalus, Normal Pressure [∗surgery]; Randomized Controlled Trials as Topic; Third
Ventricle [∗surgery]; Ventriculostomy [adverse effects; ∗methods]
MeSH check words
Humans
23Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH) (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
